Theriva Biologics Inc.
1.55
-0.36 (-18.85%)
At close: Jan 15, 2025, 3:59 PM
1.51
-2.57%
After-hours Jan 15, 2025, 04:26 PM EST

Theriva Biologics Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for TOVX stock have an median target of 6, with a low estimate of 6 and a high estimate of 6. The median target predicts an increase of 287.10% from the current stock price of 1.55.

Analyst Consensus: Buy
Target Low Average Median High
Price $6 $6 $6 $6
Change 287.10% 287.10% 287.10% 287.10%

AI Analyst Report

According to 1 stock analyst, the rating for Theriva Biologics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Nov 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
21.75M
from 0
Increased by -%
Revenue Next Year
0
from 21.75M
Increased by -100%
EPS This Year
-24.11
from -28.49
Increased by 15.4%
EPS Next Year
-9.62
from -24.11
Increased by 60.1%